Beam Therapeutics completes acquisition of Guide Therapeutics
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
BridgeBio completes acquisition of Eidos Therapeutics
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Eli Lilly completes acquisition of Prevail Therapeutics
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Anika Therapeutics completes acquisition of Arthrosurface
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Anika Therapeutics completes acquisition of Parcus Medical
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Zogenix completes acquisition of Modis Therapeutics
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
United Therapeutics completes acquisition of SteadyMed
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Aclaris completes $65M deal for rosacea treatment
Malvern-based AclarisĂ‚Â Therapeutics Inc. completed its previously announced $65 million acquisition of Rhofade, a rosacea treatment, from Allergan. The Food and Drug Administration approved Rhofade, a cream, last year as topical treatment of persis.....»»
InvaGen completes first stage closing of Avenue Therapeutics acquisition
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Beam Therapeutics price target raised to $112 from $42 at Wedbush
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Beam Therapeutics Adds To Drug Delivery With $120M GuideTx Buy
read more.....»»
Hoth Therapeutics completes pre-IND meeting with the FDA for HT-001 product
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Beam Therapeutics initiated with an Overweight at Wells Fargo
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Gemini Therapeutics completes enrollment in Phase 2a Trial of GEM103
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Gemini Therapeutics completes business combination with FSDC, debuts on Nasdaq
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
ADC Therapeutics completes enrollment in camidanlumab tesirine trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Beam Therapeutics downgraded to Neutral from Overweight at JPMorgan
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Tenax Therapeutics announces "transformative" acquisition of PH Precision Med
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Beam Therapeutics raises $260M in a private placement
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Aptevo Therapeutics completes patient dosing in cohorts 1-8 of APVO436 trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Acorda Therapeutics completes 1-for-6 reverse stock split
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»